{"id":"W4392587677","doi":"10.3390/curroncol31030106","title":"177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; London Health Sciences Centre; McMaster University; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier universitaire de Québec; Dalhousie University; Western University; University of Toronto; Jewish General Hospital; University of Calgary; McGill University; University of British Columbia","funders":"Ipsen; Astellas Pharma; Seagen; Advanced Accelerator Applications; Eisai; Sanofi; Genentech; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Taxane; Clinical trial; Oncology; Internal medicine; Adverse effect; Clinical Practice; Cabazitaxel; Observational study; Cancer; Androgen deprivation therapy; Breast cancer; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002662933,0.0009336643,0.003034863,0.005561076,0.0004634355,0.001418194,0.001634129,0.00125879,0.004206276],"category_scores_gemma":[0.004599121,0.0004492486,0.001682263,0.009128242,0.0006158143,0.001087829,0.0007606083,0.001311216,0.0006249216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004433786,"about_ca_system_score_gemma":0.01301041,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04634735,"about_ca_topic_score_gemma":0.0976101,"domain_scores_codex":[0.9992636,0.0001701549,0.0001767677,0.00007969953,0.0002653271,0.00004452833],"domain_scores_gemma":[0.9972562,0.001416967,0.000415492,0.00003461551,0.0007668387,0.0001099122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001849915,0.00003436636,0.0003681172,0.2342899,0.0008958609,0.0001393548,0.0001197299,0.0002793587,0.0002999634,0.001846615,0.02930309,0.7322387],"study_design_scores_gemma":[0.0001509463,0.0001530093,0.003921589,0.2312806,0.005276958,0.0007777654,0.0002402233,0.0001890235,0.0002572654,0.001717621,0.755977,0.00005791424],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002790672,0.9995052,0.00001481501,0.0002346718,0.00004084285,0.000004228521,0.00002025606,0.000001349913,0.0001508056],"genre_scores_gemma":[0.0002920422,0.9994354,0.00006762672,0.0001208719,0.00002076836,0.000003804538,0.00001534558,4.873195e-7,0.00004364082],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9536526,"threshold_uncertainty_score":0.09215516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5473004949041903,"score_gpt":0.6469422352170666,"score_spread":0.09964174031287631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}